You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

ROSE BENGAL SODIUM I-131 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for rose bengal sodium i-131 and what is the scope of freedom to operate?

Rose bengal sodium i-131 is the generic ingredient in two branded drugs marketed by Bracco and Sorin, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Summary for ROSE BENGAL SODIUM I-131
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Clinical Trials: 3
DailyMed Link:ROSE BENGAL SODIUM I-131 at DailyMed
Recent Clinical Trials for ROSE BENGAL SODIUM I-131

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshN/A
Universidade Federal do Rio de JaneiroPhase 4
Santen Pharmaceutical Co., Ltd.Phase 3

See all ROSE BENGAL SODIUM I-131 clinical trials

Medical Subject Heading (MeSH) Categories for ROSE BENGAL SODIUM I-131
Anatomical Therapeutic Chemical (ATC) Classes for ROSE BENGAL SODIUM I-131

US Patents and Regulatory Information for ROSE BENGAL SODIUM I-131

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sorin SODIUM ROSE BENGAL I 131 rose bengal sodium i-131 INJECTABLE;INJECTION 017318-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-003 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Bracco ROBENGATOPE rose bengal sodium i-131 INJECTABLE;INJECTION 016224-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.